CNS drugs

Which Types of Biomarkers Truly Benefit AD?

January 25 by Andrea Charles

Johannes Streffer, Director, Experimental Medicine Europe, Janssen Research & Development, Janssen Pharmaceutica NV, speaks to Andrea Charles from Pharma IQ, about where he feels the focus...

Suicidality Assessments in Clinical Trials

November 24 by Pharma IQ

In September 2010 the FDA released its Draft Guidance on Suicidality: Prospective Assessment of Occurrence in Clinical Trials that presents the FDA’s current thinking on suicida...

FIND CONTENT BY TYPE

Pharma IQ COMMUNITY

ADVERTISE WITH US

Reach Pharmaceuticals & Biotechnology professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.

Advertise Now

JOIN THE Pharma IQ COMMUNITY

Join Pharma & Biotech today and interact with a vibrant network of professionals, keeping up to date with the industry by accessing our wealth of articles, videos, live conferences and more.

Pharma IQ, a division of IQPC

Careers With IQPC| Contact Us | About Us | Cookie Policy